TUBA1B and ovarian serous cystadenocarcinoma: TUBA1B was also highly correlated with immune-related genes in many other cancers, including pancreatic adenocarcinoma (PAAD), ovarian serous cystadenocarcinoma (OV), thyroid carcinoma (THCA), kidney renal clear cell carcinoma (KIPAN + KIRC + KIRP), and prostate adenocarcinoma (PRAD), suggesting that TUBA1B may affect the immune microenvironment in these cancers (Figure 6).